The Swiss Personalized Health Network will create a new national infrastructure for sharing clinical data among university hospitals, institutes, and others involved in health research.
Proponents believe the Million European Genomes Alliance will spur research, stimulate the life sciences economy, and ultimately improve clinical care.
The resource, which builds upon the contents of the SIB-developed UniProtKB/Swiss-Prot database, aims to be a comprehensive source for human protein data, integrating proteomics and protein research repositories. Commercial partner GeneBio also plans to offer a set of for-fee tools targeted at the pharma industry.
President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.
